✦ LIBER ✦

Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide—targets for drug development?

✍ Scribed by C.J. Fowler; S.O.P. Jacobsson

Book ID: 117841363
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 231 KB
Volume: 66
Category: Article
ISSN: 0952-3278
DOI: 10.1054/plef.2001.0357

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Formulation development and manufacturin

Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study

✍ Jane K. Sosabowski; Myrto Lee; Bronwen A. Dekker; Ben P. Simmons; Surjeet Singh; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 569 KB

DFT study of a substrate and inhibitors

DFT study of a substrate and inhibitors of 1-deoxy-2-xylulose-5-phosphate reductoisomerase – the potential novel target molecule for anti-malaria drug development

✍ Igor Z. Zubrzycki; Gregory L. Blatch 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 85 KB

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity

✍ Sabine Schertl; Rolf W. Hartmann; Christine Batzl-Hartmann; Günther Bernhardt; T 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

Nuclear membrane receptors and channels

Nuclear membrane receptors and channels as targets for drug development in cardiovascular diseasesThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 1 of a 2-part Special Issue).

✍ Bkaily, Ghassan; Avedanian, Levon; Jacques, Danielle 📂 Article 📅 2009 🏛 NRC Research Press 🌐 French ⚖ 975 KB

Books of Interest Emerging Drugs and Tar

Books of Interest Emerging Drugs and Targets for Alzheimer’s Disease. Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 317 pp. 16 × 24 cm. ISBN 978-1-84973-063-1 . $249.00. Emerging Drugs and Targets for Alzheimer’s Disease. Volume 2: Neuronal Plasticity, Neuronal Protection and Other Miscellaneous Strategies . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 301 pp. 16 × 24 cm. ISBN 978-1-84973-064-8 . $249.00. Biopharmaceuticals in Plants. Toward the Next Century of Medicine . By Kathleen Laura Hefferon CRC Press , Boca Raton, FL . 2010 . xvii + 206 pp. 16 × 24 cm. ISBN 13 978-1-4398-0474-2 . $99.95. GPCR Molecular Pharmacology and Drug Targeting . Edited by Annette Gilchrist Wiley , Hoboken, NJ . 2010 . xxi + 520 pp. 16 × 24 cm. ISBN 978-0-470-30778-6 . $149.95. Drug Development Perspectives. Considerations, Challenges, and Strategies . Edited by Nuggehally R. Srinivas HNB Publishing , New York, NY . 2010 . x + 326 pp. 16 × 24 cm. ISBN 978-0-9664286-9-8 . $99.75. Chemoinformatics and Computational Chemical Biology . Edited by Jürgen Bajorath Humana Press/Springer Science , New York, NY . 2010 . x + 588 pp. 18.5 × 26 cm. ISBN 978-1-60761-838-6 . $159.00. Functional Molecules from Natural Sources . Edited by Stephen K. Wrigley , Robert Thomas , Colin T. Bedford , and Neville Nicholson Royal Society of Chemistry , Cambridge, U.K. 2011 . x + 233 pp. 16 × 24 cm. ISBN 978-1-84755-259-4 . £109.99.

📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 606 KB